Format

Send to

Choose Destination
See comment in PubMed Commons below

Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment [Internet].

Source

Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 May.
AHRQ Comparative Effectiveness Reviews.

Author information

1
Blue Cross and Blue Shield Association Technology Evaluation Center EPC, Chicago, Illinois

Excerpt

This review compares the efficacy and adverse effects of specific erythropoietic stimulants (i.e., epoetin [alfa or beta], darbepoetin alfa) when used to manage anemia in patients undergoing cancer therapy (i.e., chemotherapy and/or radiation). This review also addresses questions relevant to optimizing the use of erythropoietic stimulants as a general class: the outcomes of using alternative thresholds to initiate or discontinue treatment and whether there are early predictors of response to treatment.

PubMed Commons home

PubMed Commons

0 comments
    Support Center